What Happened? A number of stocks jumped in the afternoon session after the government announced a surprise increase in payment rates for Medicare Advantage ...
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how health insurance ...
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. Not...
What Happened? A number of stocks jumped in the afternoon session after easing crude oil prices helped lift investor sentiment and reduce inflation worries. ...
A clean balance sheet can signal disciplined management and stability. It also means a company can expand and thrive without relying on borrowed capital. Eve...
"You get what you pay for" often applies to expensive stocks with best-in-class business models and execution.
While their quality can sometimes justify the premium, they typically experience elevated volatility during market downturns when expectations change.
A number of stocks fell in the afternoon session after a surprisingly hot wholesale inflation report fueled investor concerns about persistent price pressures.
Health insurance company Alignment Healthcare (NASDAQ:ALHC) reported revenue ahead of Wall Street’s expectations in Q4 CY2025, with sales up 44.4% year on year to $1.01 billion. On the other hand, next quarter’s revenue guidance of $1.22 billion was less impressive, coming in 1.9% below analysts’ estimates. Its GAAP loss of $0.05 per share was 67.1% above analysts’ consensus estimates.
Health insurance company Alignment Healthcare (NASDAQ:ALHC)
will be reporting results this Thursday after market hours. Here’s what investors should know.
Wall Street has set ambitious price targets for the stocks in this article.
While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional pressures that can sometimes lead to overly optimistic forecasts.
Humana Inc. (NYSE:HUM) shares experienced a sharp sell-off this week after the health insurance giant issued a surprisingly conservative financial outlook for 2026. The company warned investors that a massive $3.5 billion net headwind stemming from a decline in Medicare Advantage (MA) Star Ratings would severely compress margins,
When Wall Street turns bearish on a stock, it’s worth paying attention.
These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other business lines such as M&A advisory.
Stocks trading between $10 and $50 can be particularly interesting as they frequently represent businesses that have survived their early challenges.
However, investors should remain vigilant as some may still have unproven business models, leaving them vulnerable to the ebbs and flows of the broader market.
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Those leading the charge have not only realized strong financial performance but also propelled the broader industry’s returns
as healthcare stocks have gained 18.7% over the past six months while the S&P 500 was up 9.8%.
